Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where
Dr Lal Pathlabs Ltd Q1FY25; 29% rise in Profits
Categories
Healthcare Services
Sumitomo Chemical India Ltd Q1FY25; 106% rise in Profits
Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as
Apollo Hospitals Enterprise Limited Q4 FY24 Earnings Conference Call Insights
Key highlights from Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q4 FY24 Earnings Concall Capital Raise Apollo HealthCo to raise equity capital of INR
Sanofi India Ltd Q3FY24; 5% rise in Profits
Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Financial Results: Sanofi India Ltd reported Revenues for Q3FY24
Dr Lal Pathlabs Ltd Q3FY24; 52% rise in Profits
Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where
Vijaya Diagnostic Centre Ltd Q3FY24; 62% rise in Profits
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Metropolis Healthcare Ltd Q3FY24; 25% fall in Profits
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South
Procter & Gamble Health Ltd Q2FY24; 3% rise in Profits
P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals
Dr Lal PathLabs Ltd Q2 FY24 Earnings Conference Call Insights
Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q2 FY24 Earnings Concall Financial Performance Revenue for Q2 FY24 was INR601 crores, up
Shivalik Rasayan Ltd Q1FY24; 23% fall in Profits
The company is into manufacturing of agrochemicals and in 2015 it forayed into pharmaceuticals.The company acquired Medicamen Biotech Limited in 2015 which
Max Healthcare Institute Ltd Q1FY24; 39% rise in Profits
Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and
Star Health & Allied Insurance Company Ltd Q1FY24; 35% rise in Profits
Star Health & Allied Insurance Ltd (Star) is India’s first Standalone Health Insurance provider and is the largest private health insurer in
Apollo Hospitals Enterprise Limited Q4 FY23 Earnings Conference Call Insights
Key highlights from Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q4 FY23 Earnings Concall Management Update: [00:08:21] APOLLOHOSP said it has made significant progress
Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q4 FY23 Earnings Concall Transcript
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Q4 FY23 Earnings Concall dated May. 31, 2023 Corporate Participants: Mayank Vaswani -- Investor Relations Suneeta Reddy
Hester Biosciences Limited (HESTERBIO) Q4 FY23 Earnings Concall Transcript
Hester Biosciences Limited (NSE:HESTERBIO) Q4 FY23 Earnings Concall dated May. 18, 2023. Corporate Participants: Bimal Lalitsingh Goculdas -- Chief Executive Officer Analysts: Abhishek Mehra -- TIL
Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY23 Earnings Concall Transcript
Dr Lal PathLabs Ltd (NSE:LALPATHLAB) Q4 FY23 Earnings Concall dated May. 11, 2023. Corporate Participants: Hon. Brig. Dr. Arvind Lal -- Executive Chairman Om
Metropolis Healthcare Limited (METROPOLIS) Q4 FY23 Earnings Concall Transcript
Metropolis Healthcare Limited (NSE: METROPOLIS) Q4 FY23 earnings concall dated May. 16, 2023 Corporate Participants: Ameera Shah -- Managing Director Surendran Chemmenkotil -- Chief Executive Officer
Max Healthcare Institute Ltd (MAXHEALTH) Q4 FY23 Earnings Concall Transcript
Max Healthcare Institute Ltd (NSE: MAXHEALTH) Q4 FY23 earnings concall dated May. 17, 2023 Corporate Participants: Abhay Soi -- Chairman and Managing Director Yogesh
Rainbow Children’s Medicare Ltd (RAINBOW) Q4 FY23 Earnings Concall Transcript
Rainbow Children's Medicare Ltd (NSE: RAINBOW) Q4 FY23 earnings concall dated May. 15, 2023 Corporate Participants: Ramesh Kancharla -- Chairman and Managing Director Sanjeev
Dr Lal PathLabs Ltd Q4 FY23 Earnings Conference Call Insights
Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY23 Earnings Concall Q&A Highlights: [00:17:48] Rahul Agarwal from InCred Capital asked if
Neuland Laboratories Limited (NEULANDLAB) Q4 FY23 Earnings Concall Transcript
Neuland Laboratories Limited (NSE:NEULANDLAB) Q4 FY23 Earnings Concall dated May. 11, 2023. Corporate Participants: Ravi Udeshi -- Investor Relations Abhijit Majumdar. -- Chief Financial Officer Saharsh